Reduce the frequency of flares with ARCALYST®, the first and only FDA approved therapy for Recurrent Pericarditis in patients 12 years or older.

May 1, 2025 · Arcalyst (rilonacept) is used to treat Cryopyrin-Associated Periodic Syndromes, Deficiency of Interleukin-1 Receptor Antagonist, and recurrent pericarditis. Includes Arcalyst side effects, …

Rilonacept, sold under the brand name Arcalyst, is a medication used to treat cryopyrin-associated periodic syndromes, including familial cold autoinflammatory syndrome, and Muckle–Wells …

ARCALYST (rilonacept) is an interleukin-1 blocker indicated for the treatment of Cryopyrin-Associated Periodic Syndromes (CAPS), including Familial Cold Autoinflammatory Syndrome (FCAS) and...

ARCALYST (rilonacept) is the only FDA-approved therapy to treat recurrent pericarditis and reduce the risk of recurrence in patients 12 years and older.

Sep 15, 2024 · Find patient medical information for Arcalyst (rilonacept) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

Feb 1, 2026 · Rilonacept injection is used to treat cryopyrin-associated periodic syndromes (CAPS), including familial cold autoinflammatory syndrome (FCAS) and Muckle-Wells syndrome (MWS). …

FDA has approved Arcalyst (rilonacept) injection to treat recurrent pericarditis and reduce the risk of recurrence in adults and children 12 years and older.

Jun 3, 2024 · ARCALYST® (rilonacept) is an interleukin-1 blocker indicated for the treatment of Cryopyrin-Associated Periodic Syndromes (CAPS), including Familial Cold Autoinflammatory …

Dec 16, 2025 · ARCALYST (rilonacept) for injection is supplied as a sterile, white to off-white, preservative-free, lyophilized powder in single-dose vials. Each 220 mg vial of ARCALYST is …